Document is current
Any future updates will be listed below
-
Authors
Pinch, Benika J. https://orcid.org/0000-0003-2957-6903
Doctor, Zainab M.
Nabet, Behnam https://orcid.org/0000-0002-6738-4200
Browne, Christopher M.
Seo, Hyuk-Soo https://orcid.org/0000-0003-0646-2102
Mohardt, Mikaela L.
Kozono, Shingo https://orcid.org/0000-0003-3898-6373
Lian, Xiaolan
Manz, Theresa D.
Chun, Yujin
Kibe, Shin https://orcid.org/0000-0001-8197-0313
Zaidman, Daniel
Daitchman, Dina
Yeoh, Zoe C.
Vangos, Nicholas E.
Geffken, Ezekiel A.
Tan, Li https://orcid.org/0000-0002-1199-9046
Ficarro, Scott B.
London, Nir
Marto, Jarrod A. https://orcid.org/0000-0003-2086-1134
Buratowski, Stephen
Dhe-Paganon, Sirano
Zhou, Xiao Zhen
Lu, Kun Ping
Gray, Nathanael S. https://orcid.org/0000-0001-5354-7403
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (F31 CA225066)
U.S. Department of Health & Human Services | National Institutes of Health (T32 GM007306)
U.S. Department of Health & Human Services | National Institutes of Health (T32 GM095450-04)
U.S. Department of Health & Human Services | National Institutes of Health (R01 CA19850)
U.S. Department of Health & Human Services | National Institutes of Health (R01 GM056663)
U.S. Department of Health & Human Services | National Institutes of Health (R01 CA205153)
U.S. Department of Health & Human Services | National Institutes of Health (R01 CA205153)
U.S. Department of Health & Human Services | National Institutes of Health (R01 CA205153)
U.S. Department of Health & Human Services | National Institutes of Health (R01 CA205153)
American Cancer Society (PF-17-010-01-CDD)
Israel Science Foundation (2462/19)
- License Information
-
More Information
Article History
Received: 9 May 2019
Accepted: 15 April 2020
First Online: 1 June 2020
Competing interests
: N.S.G. is a Scientific Founder and member of the Scientific Advisory Board (SAB) of C4 Therapeutics, Syros, Soltego, Gatekeeper and Petra Pharmaceuticals, and has received research funding from Novartis, Astellas, Taiho and Deerfield. J.A.M. serves on the SAB of 908 Devices, Boston, MA, and receives sponsored research support from Vertex and AstraZeneca. N.L. is a member of the SAB of Trilogy Sciences and has received research support from Teva. B.J.P., N.S.G., H.-S.S., S.D.-P., Z.M.D., C.M.B., J.A.M., S. Kozono, X.L., K.P.L. and X.Z.Z. are inventors on a patent application related to the Pin1 inhibitors described in this manuscript (WO/2019/241496). B.N. is an inventor on patent applications related to the dTAG system described in this manuscript (WO/2017/024318, WO/2017/024319, WO/2018/148443, WO/2018/148440). K.P.L. and X.Z.Z. are inventors on many issued patents or pending patent applications related to Pin1 inhibitors and/or biomarkers.
